According to the latest U.S. Bureau of Labor Statistics’ report, the Seasonally Adjusted Food-at-Home Consumer Price Index increased 1.6% and 0.4% for the thirteen week periods ended March 30, 2024 and April 1, 2023, respectively. According to the U.S. Department of Energy, the average price of gasoline in the Central Atlantic States decreased 5.0% or $0.18 per gallon in the thirteen weeks ended March 30, 2024, compared to the same period in 2023. Even though the U.S. Bureau of Labor Statistics’ and the U.S. Department of Energy indices may be reflective of a trend, it will not necessarily be indicative of the Company’s actual results.
Comparable store sales for the thirteen weeks ended March 30, 2024, compared to the same period in 2023 increased 3.3% excluding fuel and 3.1% including fuel. Comparable store sales adjusted for the Easter holiday shift for the thirteen weeks ended March 30, 2024, compared to the same period in 2023 increased 1.9%. On a comparable store sales basis pharmacy services increased in sales.
Total net sales for the thirteen weeks ended March 30, 2024, compared to the same period in 2023 increased 3.3% excluding fuel and 2.9% including fuel. Total net sales adjusted for the Easter holiday shift for the thirteen weeks ended March 30, 2024, compared to the same period in 2023 increased 2.0%. The Company’s first quarter sales benefited from the Easter holiday period, which occured in the second quarter last year. Management estimates the incremental holiday sales impact was approximately $14.0 million.
Although the Company experienced retail inflation and deflation in various commodities for the periods presented, the Company anticipates overall product costs to increase given the recent inflationary indicators in the food retail industry. Management cannot accurately measure the full impact of inflation or deflation on retail pricing due to changes in the types of merchandise sold between periods, shifts in customer buying patterns and the fluctuation of competitive factors. Management remains confident in its ability to generate long-term sales growth in a highly competitive environment, but also understands some competitors have greater financial resources and could use these resources to take measures which could adversely affect the Company’s competitive position.
Cost of Sales and Gross Profit
Cost of sales consists of direct product costs (net of discounts and allowances), net advertising costs, distribution center and transportation costs, as well as manufacturing facility operations.
Gross profit on sales increased 1.8% for the thirteen weeks ended March 30, 2024, compared to the same period in 2023. Gross profit margin decreased 0.3% for the thirteen weeks ended March 30, 2024, compared to the same period in 2023. The Company experienced degradation in its gross profit margin as product costs increased in the fresh meats and pharmacy departments and lower margin departments, such as pharmacy, increased in the product mix.
Non-cash LIFO inventory valuation adjustments represent expense of $1.4 million in the first thirteen weeks of 2024 compared to expense of $1.6 million in the same period in 2023. Although the Company experienced cost inflation and deflation in various commodities for the periods presented, the Company anticipates overall product costs to increase given the recent inflationary trends in the food retail industry.
Operating, General and Administrative Expenses
The majority of the operating, general and administrative expenses are driven by sales volume.
Employee expenses such as wages, employer paid taxes, health care benefits and retirement plans, comprise approximately 59.2% of the total “Operating, general and administrative expenses.” As a percent of sales, direct store labor was unchanged in the thirteen week period ended March 30, 2024 when compared to the same period in 2023.
Depreciation and amortization expense charged to “Operating, general and administrative expenses” was $24.8 million, or 2.1% of net sales during the thirteen weeks ended March 30, 2024 compared to $24.1 million, or 2.1% of net sales during the thirteen weeks ended April 1, 2023. See the Liquidity and Capital Resources section for further information regarding the Company’s capital expenditure program.